Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Pathogenesis of Mycosis Fungoides
Michael Girardi, Peter Heald, Lynn D. Wilson
New England Journal of Medicine (2004) Vol. 350, Iss. 19, pp. 1978-1988
Closed Access | Times Cited: 380

Showing 26-50 of 380 citing articles:

Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma
Youn H. Kim, Michael Girardi, Madeleine Duvic, et al.
Journal of the American Academy of Dermatology (2010) Vol. 63, Iss. 6, pp. 975-983
Closed Access | Times Cited: 109
Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome
Thorbjørn Krejsgaard, Niels Ødum, Carsten Geisler, et al.
Leukemia (2011) Vol. 26, Iss. 3, pp. 424-432
Closed Access | Times Cited: 107
Malignant Cutaneous T-Cell Lymphoma Cells Express IL-17 Utilizing the Jak3/Stat3 Signaling Pathway
Thorbjørn Krejsgaard, Ulrik Ralfkiær, Erik Clasen‐Linde, et al.
Journal of Investigative Dermatology (2011) Vol. 131, Iss. 6, pp. 1331-1338
Open Access | Times Cited: 104
IL-22, but Not IL-17, Dominant Environment in Cutaneous T-cell Lymphoma
Tomomitsu Miyagaki, Makoto Sugaya, Hiraku Suga, et al.
Clinical Cancer Research (2011) Vol. 17, Iss. 24, pp. 7529-7538
Closed Access | Times Cited: 102
Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma
Magdalena B. Wozniak, Raquel Villuendas, James R. Bischoff, et al.
Haematologica (2010) Vol. 95, Iss. 4, pp. 613-621
Open Access | Times Cited: 98
Immune Function Abnormalities in Peripheral Blood Mononuclear Cell Cytokine Expression Differentiates Stages of Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Benjamin F. Chong, Adam J. Wilson, Heather M. Gibson, et al.
Clinical Cancer Research (2008) Vol. 14, Iss. 3, pp. 646-653
Open Access | Times Cited: 98
T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides
Kari E. Sufficool, Christina M. Lockwood, Haley Abel, et al.
Journal of the American Academy of Dermatology (2015) Vol. 73, Iss. 2, pp. 228-236.e2
Open Access | Times Cited: 90
Prevalence and Severity of Pruritus and Quality of Life in Patients With Cutaneous T-Cell Lymphoma
A Wright, Aruni Wijeratne, Tracy Hung, et al.
Journal of Pain and Symptom Management (2012) Vol. 45, Iss. 1, pp. 114-119
Open Access | Times Cited: 86
Thymic Stromal Chemokine TSLP Acts through Th2 Cytokine Production to Induce Cutaneous T-cell Lymphoma
N. Takahashi, Makoto Sugaya, Hiraku Suga, et al.
Cancer Research (2016) Vol. 76, Iss. 21, pp. 6241-6252
Closed Access | Times Cited: 85
Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma
Melania H. Fanok, Amy Sun, Laura K. Fogli, et al.
Journal of Investigative Dermatology (2017) Vol. 138, Iss. 5, pp. 1116-1125
Open Access | Times Cited: 85
Bacterial Toxins Fuel Disease Progression in Cutaneous T-Cell Lymphoma
Andreas Willerslev-Olsen, Thorbjørn Krejsgaard, Lise M. Lindahl, et al.
Toxins (2013) Vol. 5, Iss. 8, pp. 1402-1421
Open Access | Times Cited: 84
CCR4 in cutaneous T‐cell lymphoma: Therapeutic targeting of a pathogenic driver
Jan P. Nicolay, Jana D. Albrecht, Silvia Alberti Violetti, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 7, pp. 1660-1671
Open Access | Times Cited: 42
Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma
Yuxin Du, Yun Cai, Yan Lv, et al.
Cancer Letters (2022) Vol. 551, pp. 215972-215972
Open Access | Times Cited: 36
Chlormethine gel in combination with other therapies for treatment of mycosis fungoides: a review with patient cases
Marco Ardigò, Neda Nikbakht, Miriam Teoli, et al.
Frontiers in Medicine (2024) Vol. 10
Open Access | Times Cited: 6
Gut microbiota analyses of cutaneous T-cell lymphoma patients undergoing narrowband ultraviolet B therapy reveal alterations associated with disease treatment
William Nguyen, Lauren P. Chrisman, Gail L. Enriquez, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 5
Second Lymphomas and Other Malignant Neoplasms in Patients With Mycosis Fungoides and Sézary Syndrome
Kathie P. Huang, Martin A. Weinstock, Christina A. Clarke, et al.
Archives of Dermatology (2007) Vol. 143, Iss. 1
Closed Access | Times Cited: 100
Low FAS/CD95 Expression by CTCL Correlates with Reduced Sensitivity to Apoptosis that Can Be Restored by FAS Upregulation
Jianqiang Wu, Minakshi Nihal, Jawed A. Siddiqui, et al.
Journal of Investigative Dermatology (2008) Vol. 129, Iss. 5, pp. 1165-1173
Open Access | Times Cited: 94
Pruritus in Cutaneous T-cell Lymphomas: Frequent, Often Severe and Difficult to Treat
Nicolás Meyer, C. Paul, L. Misery
Acta Dermato Venereologica (2010) Vol. 90, Iss. 1, pp. 12-17
Open Access | Times Cited: 71
Increased CCL18 expression in patients with cutaneous T‐cell lymphoma: association with disease severity and prognosis
Tomomitsu Miyagaki, Makoto Sugaya, Hiraku Suga, et al.
Journal of the European Academy of Dermatology and Venereology (2012) Vol. 27, Iss. 1
Closed Access | Times Cited: 69
Simplified Flow Cytometric Assessment in Mycosis Fungoides and Sézary Syndrome
Alexandra C. Hristov, Eric C. Vonderheid, Michael J. Borowitz
American Journal of Clinical Pathology (2011) Vol. 136, Iss. 6, pp. 944-953
Open Access | Times Cited: 69
Mycosis Fungoides
Sophie X. Song, Rein Willemze, Steven H. Swerdlow, et al.
American Journal of Clinical Pathology (2013) Vol. 139, Iss. 4, pp. 466-490
Closed Access | Times Cited: 67
Deficient Cutaneous Antibacterial Competence in Cutaneous T-Cell Lymphomas: Role of Th2-Mediated Biased Th17 Function
Kerstin Wolk, Hiroshi Mitsui, Katrin Witte, et al.
Clinical Cancer Research (2014) Vol. 20, Iss. 21, pp. 5507-5516
Open Access | Times Cited: 65
Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis
Yuanshen Huang, Ivan V. Litvinov, Yang Wang, et al.
Oncotarget (2014) Vol. 5, Iss. 12, pp. 4418-4425
Open Access | Times Cited: 61
The Role of IL-32 in Cutaneous T-Cell Lymphoma
Hiraku Suga, Makoto Sugaya, Tomomitsu Miyagaki, et al.
Journal of Investigative Dermatology (2013) Vol. 134, Iss. 5, pp. 1428-1435
Open Access | Times Cited: 60
Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside
William Damsky, Jaehyuk Choi
Current Treatment Options in Oncology (2016) Vol. 17, Iss. 7
Closed Access | Times Cited: 59

Scroll to top